Effects of electroconvulsive therapy on serum levels of brain-derived neurotrophic factor and nerve growth factor in treatment resistant major depression

Brain Research Bulletin

Volumn 104, Issue , 2014, Pages 82-87

  Bilgen, Ali Emrah ^a   Bozkurt Zincir, Selma ^b   Zincir, Serkan ^c   Özdemir, Barbaros ^d   Ak, Mehmet ^e   Aydemir, Emre ^d   Şener, Irfan ^d  

^a Etimesgut Asker Hastanesi   (Turkey)

^b Erenkoy Research and Training Hospital for Mental and Neurological Disorders   (Turkey)

^c Gölcük Asker Hastanesi Department of Psychiatry ^*  (Turkey)

^d GULHANE SCHOOL OF MEDICINE   (Turkey)

^e Memorial Hospital Department of Psychiatry   (Turkey)

Author keywords

Brain derived neurotrophic factor; Electroconvulsive therapy; Major depression; Nerve growth factor

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; NERVE GROWTH FACTOR;

ADULT; ARTICLE; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE SEVERITY; ELECTROCONVULSIVE THERAPY; FEMALE; HUMAN; MAJOR DEPRESSION; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY; STATISTICAL SIGNIFICANCE; TREATMENT RESISTANT DEPRESSION; BLOOD; DEPRESSIVE DISORDER, MAJOR; DEPRESSIVE DISORDER, TREATMENT-RESISTANT;

ADULT; BRAIN-DERIVED NEUROTROPHIC FACTOR; DEPRESSIVE DISORDER, MAJOR; DEPRESSIVE DISORDER, TREATMENT-RESISTANT; ELECTROCONVULSIVE THERAPY; FEMALE; HUMANS; MALE; NERVE GROWTH FACTOR;

EID: 84899954509     PISSN: 03619230     EISSN: 18732747     Source Type: Journal    
DOI: 10.1016/j.brainresbull.2014.04.005     Document Type: Article

References (34)

1. Angelucci F., Aloe L., Vasquez P.J., Mathe A.A. Mapping the differences in the brain concentration of brain-derived neurotrophic factor (BDNF) and nerve growth factor (NGF) in an animal model of depression. Neuroreport 2000, 27:1369-1373.
2. Angelucci F., Aloe L., Jimenez-Vasquez P., Mathe A.A. Electroconvulsive stimuli alter nerve growth factor but not brain-derived neurotrophic factor concentrations in brains of a rat model of depression. Neuropeptides 2003, 37:51-56.
3. Aydemir O., Deveci A., Taneli F. The effect of chronic antidepressant treatment on serum brain-derived neurotrophic factor levels in depressed patients: a preliminary study. Prog. Neuropsychopharmacol. Biol. Psychiatry 2005, 29:261-265.
4. Bocchio-Chiavetto L., Bagnardi V., Zanardini R., Molteni R., Nielsen M.G., Placentino A. Serum and plasma BDNF levels in major depression: a replication study and meta-analyses. World J. Biol. Psychiatry 2010, 11:763-773.
5. Bocchio-Chiavetto L., Zanardini R., Bortolomasi M., Abate M., Segala M., Giacopuzzi M. Electroconvulsive Therapy (ECT) increases serum brain derived neurotrophic factor (BDNF) in drug resistant depressed patients. Eur. Neuropsychopharmacol. 2006, 16:620-624.
6. Bus B.A., Molendijk M.L., Penninx B.J., Buitelaar J.K., Kenis G., Prickaerts J. Determinants of serum brain-derived neurotrophic factor. Psychoneuroendocrinology 2011, 36:228-239.
7. Brunoni A.R., Lopes M., Frengi F. A systematic review and meta-analysis of clinical studies on major depression and BDNF levels: implications for the role of neuroplasticity in depression. Int. J. Neuropsychopharmacol. 2008, 11:1169-1180.
8. Carvey P.M. Drug Action in the Central Nervous System 1998, 123-150. Oxford University, New York.
9. Fernandes B., Gama C.S., Massuda R., Torres M., Camargo D., Kunz M. Serum brain-derived neurotrophic factor (BDNF) is not associated with response to electroconvulsive therapy (ECT): a pilot study in drug resistant depressed patients. Neurosci. Lett. 2009, 453:195-198.
10. Gedge L., Beaudoin A., Lazowski L., du Toit R., Jokic R., Milev R. Effects of electroconvulsive therapy and repetitive transcranial magnetic stimulation on serum brain-derived neurotrophic factor levels in patients with depression. Front. Psychiatry 2012, 12.
11. Gönül A.S., Akdeniz F., Taneli F., Donat O., Eker C., Vahip S. Effect of treatment on serum brain-derived neurotrophic factor levels in depressed patients. Eur. Arch. Psychiatry Clin. Neurosci. 2005, 255:381-386.
12. Grönli O., Stensland G.O., Wynn R., Olstad R. Neurotrophic factors in serum following ECT: a pilot study. World J. Biol. Psychiatry 2009, 10:295-301.
13. Hadjiconstantinou M., Mcguire L., Duchemin A.M., Laskowski B., Kiecolt-Glaser J., Glaser R. Changes in plasma NGF levels in older adults associated with chronic stress. J. Neuroimmunol. 2001, 116:102-106.
14. Haghighi M., Salehi I., Erfani P., Jahangard L., Bajoghli H., Holsboer-Trachsler E. Additional ECT increases BDNF-levels in patients suffering from major depressive disorders compared to patients treated with citalopram only. J. Psychiatr. Res. 2013, 47:908-915.
15. Hu Y., Yu X., Yang F., Si T., Wang W., Tan Y. The level of serum brain-derived neurotrophic factor is associated with the therapeutic efficacy of modified electroconvulsive therapy in Chinese patients with depression. J. ECT 2010, 26:121-125.
16. Huang T.L., Hung Y.Y. Lorazepam reduces the serum brain-derived neurotrophic factor level in schizophrenia patients with catatonia. Prog. Neuropsychopharmacol. Biol. Psychiatry 2009, 33:158-159.
17. Huopaniemi L., Keist R., Randolph A., Certa U., Rudolph U. Diazepam-induced adaptive plasticity revealed by α1 GABA-A receptor-specific expression profiling. J. Neurochem. 2004, 88:1059-1067.
18. Karege F., Perret G., Bondolfi G., Schwald M., Bertschy G., Aubry J.M. Decreased serum brain-derived neurotrophic factor levels in major depressed patients. Psychiatry Res. 2002, 109:143-148.
19. Karege F., Schwald M., Cisse M. Postnatal developmental profile of brain-derived neurotrophic factor in rat brain and platelets. Neurosci. Lett. 2002, 328:261-264.
20. Kim J., Gale K., Kondratyev A. Effects of repeated minimal electroshock seizures on NGF, BDNF and FGF-2 protein in the rat brain during postnatal development. Int. J. Dev. Neurosci. 2010, 28:227-232.
21. Kotan Z., Sarandöl A., Saygin E.S., Akkaya C. Depression, neuroplasticity and neurotrophic factors. Curr. Approach. Psychiatry 2009, 1:22-35.
22. Lee J., Duan W., Mattson M.P. Evidence that brain-derived neuro-trophic factor is required for basal neurogenesis and mediates in part the enhancement of neurogenesis by dietary restriction in the hippocampus of adult mice. J. Neurochem. 2002, 82:1367-1375.
23. Martino M., Rocchi G., Escelsior A., Contini P., Colicchio S., de Berardis D. NGF serum levels variations in major depressed patients receiving duloxetine. Psychoneuroendocrinology 2013, 13:47-54.
24. Murray C.J., Lopez A.D. Alternative projections of mortality and disability by cause 1990-2020. Global Burden of Disease Study. Lancet 1997, 349:1498-1504.
25. Nierenberg A.A., Amsterdam J.D. Treatment-resistant depression: definition and treatment approaches. J. Clin. Psychiatry 1990, 51:39-47. discussion 48-50.
26. Okamoto T., Yoshimura R., Ikenouchi-Sugita A., Hori H., Umene-Nakano W., Inoue Y. Efficacy of electroconvulsive therapy is associated with changing blood levels of homovanillic acid and brain-derived neurotrophic factor (BDNF) in refractory depressed patients: a pilot study. Prog. Neuropsychopharmacol. Biol. Psychiatry 2008, 32:1185-1190.
27. Piccinni A., Del Debbio A., Medda P., Bianchi C., Roncaglia I., Veltri A. Plasma Brain-Derived Neurotrophic Factor in treatment-resistant depressed patients receiving ECT. Eur. Neuropsychopharmacol. 2009, 19:349-355.
28. Reus G.Z., Stringari R.B., Ribeiro K.F., Cipriano A.L., Panizzutti B.S., Stertz L. Maternal deprivation induces depressive-like behaviour and alters neurotrophin levels in the rat brain. Eurochem. Res. 2011, 36:460-466.
29. Sala M., Perez J., Soloff P., Ucelli di Nemi S., Caverzasi E., Soares J.C. Stress and hippocampal abnormalities in psychiatric disorders. Eur. Neuropsychopharmacol. 2004, 14:393-405.
30. Schulte-Herbruggen O., Fuchs E., Abumaria N., Ziegler A., Danker-Hopfe H., Hiemke C. Effects of escitalopram on the regulation of brain-derived neurotrophic factor and nerve growth factor protein levels in a rat model of chronic stress. J. Neurosci. Res. 2009, 87:2551-2560.
31. Shirayama Y., Chen A.C., Nakagawa S., Russell D.S., Duman R.S. Brain-derived neurotrophic factor produces antidepressant effects in behavioral models of depression. J. Neurosci. 2002, 22:3251-3261.
32. Stahl S.M. Essential Psychopharmacology: Neuroscientific Basis and Practical Applications 2012, (T. Uzbay, Trans.), Istanbul Medical Publishing. 3rd ed.
33. Xiong P., Zeng Y., Wan J., Xiaohan D.H., Tan D., Lu J. The role of NGF and IL-2 serum level in assisting the diagnosis in first episode schizophrenia. Psychiatry Res. 2011, 189:72-76.
34. Yuluǧ B., Ozan E., Gönül A.S., Kiliç E. Brain derived neurotrophic factor, stress and depression: a minireview. Brain Res. Bull. 2009, 78:267-269.